Phreesia (NYSE:PHR) Shares Down 12% – Should You Sell?

Phreesia, Inc. (NYSE:PHR) fell 12% during mid-day trading on Friday . The company traded as low as $18.26 and last traded at $18.48. 81,020 shares were traded during trading, a decline of 82% from the average session volume of 445,655 shares. The stock had previously closed at $21.00.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on PHR. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research note on Thursday, September 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a research report on Friday, September 27th. Needham & Company LLC reissued a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Thursday, September 5th. Truist Financial upped their price objective on Phreesia from $29.00 to $31.00 and gave the company a “buy” rating in a report on Friday, September 6th. Finally, DA Davidson reiterated a “buy” rating and set a $32.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, Phreesia presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.42.

Phreesia Stock Performance

The company’s 50 day moving average price is $21.28 and its 200-day moving average price is $22.01. The stock has a market cap of $1.04 billion, a P/E ratio of -10.02 and a beta of 0.94. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.77 and a current ratio of 1.77.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Wednesday, September 4th. The company reported ($0.31) EPS for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.06. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. The business had revenue of $102.12 million for the quarter, compared to analyst estimates of $101.76 million. Equities analysts forecast that Phreesia, Inc. will post -1.23 EPS for the current fiscal year.

Insider Buying and Selling at Phreesia

In other news, General Counsel Allison C. Hoffman sold 14,110 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $26.03, for a total value of $367,283.30. Following the sale, the general counsel now directly owns 121,003 shares of the company’s stock, valued at approximately $3,149,708.09. This represents a 10.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Yvonne Hui sold 2,791 shares of the firm’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $20.92, for a total transaction of $58,387.72. Following the completion of the transaction, the insider now directly owns 27,228 shares of the company’s stock, valued at approximately $569,609.76. The trade was a 9.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 44,107 shares of company stock valued at $1,035,226 over the last three months. 5.80% of the stock is currently owned by insiders.

Institutional Trading of Phreesia

Several hedge funds have recently added to or reduced their stakes in PHR. International Assets Investment Management LLC lifted its position in Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after purchasing an additional 1,395 shares during the last quarter. nVerses Capital LLC grew its holdings in Phreesia by 76.5% in the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock worth $64,000 after acquiring an additional 1,300 shares during the last quarter. EntryPoint Capital LLC purchased a new position in shares of Phreesia in the first quarter valued at about $169,000. Quadrature Capital Ltd bought a new position in shares of Phreesia during the first quarter valued at about $202,000. Finally, Lombard Odier Asset Management USA Corp purchased a new stake in shares of Phreesia during the second quarter worth about $202,000. 92.10% of the stock is owned by institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.